ANI Pharmaceuticals, Inc. (BSFA.SG)
- Previous Close
59.50 - Open
59.50 - Bid 60.00 x 150000
- Ask 62.00 x 150000
- Day's Range
59.50 - 60.00 - 52 Week Range
33.00 - 64.00 - Volume
0 - Avg. Volume
3 - Market Cap (intraday)
1.278B - Beta (5Y Monthly) 0.80
- PE Ratio (TTM)
75.95 - EPS (TTM)
0.79 - Earnings Date May 10, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
www.anipharmaceuticals.com642
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: BSFA.SG
Performance Overview: BSFA.SG
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BSFA.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BSFA.SG
Valuation Measures
Market Cap
1.28B
Enterprise Value
1.36B
Trailing P/E
75.72
Forward P/E
14.18
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.41
Price/Book (mrq)
3.12
Enterprise Value/Revenue
2.80
Enterprise Value/EBITDA
12.77
Financial Highlights
Profitability and Income Statement
Profit Margin
3.86%
Return on Assets (ttm)
3.72%
Return on Equity (ttm)
4.72%
Revenue (ttm)
486.82M
Net Income Avi to Common (ttm)
15.47M
Diluted EPS (ttm)
0.79
Balance Sheet and Cash Flow
Total Cash (mrq)
221.12M
Total Debt/Equity (mrq)
63.67%
Levered Free Cash Flow (ttm)
112.78M
Company Insights: BSFA.SG
BSFA.SG does not have Company Insights